Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics

被引:69
|
作者
Cross, KJ
Wharton, SA
Skehel, JJ
Wiley, DC
Steinhauer, DA
机构
[1] Natl Inst Med Res, London NW7 1AA, England
[2] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[3] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA
来源
EMBO JOURNAL | 2001年 / 20卷 / 16期
关键词
fusion; hemagglutinin; influenza; reverse genetics;
D O I
10.1093/emboj/20.16.4432
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Influenza haemagglutinin (HA) is responsible for fusing viral and endosomal membranes during virus entry. In this process, conformational. changes in the RA relocate the HA(2) N-terminal 'fusion peptide' to interact with the target membrane. The highly conserved HA fusion peptide shares composition and sequence features with functionally analogous regions of other viral fusion proteins, including the presence and distribution of glycines and large side-chain hydrophobic residues. HAs with mutations in the fusion peptide were expressed using vaccinia virus recombinants to examine the requirement for fusion of specific hydrophobic residues and the significance of glycine spacing. Mutant HAs were also incorporated into infectious influenza viruses for analysis of their effects on infectivity and replication. In most cases alanine, but not glycine substitutions for the large hydrophobic residues, yielded fusion-competent HAs and infectious viruses, suggesting that the conserved spacing of glycines may be structurally significant. When viruses containing alanine substitutions for large hydrophobic residues were passaged, pseudoreversion to valine was observed, indicating a preference for large hydrophobic residues at specific positions. Viruses were also obtained with serine, leucine or phenylalanine as the N-terminal residue, but these replicated to significantly lower levels than wild-type virus with glycine at this position.
引用
收藏
页码:4432 / 4442
页数:11
相关论文
共 50 条
  • [21] Using reverse genetics to screen for glh mutants
    Coberly, EA
    Montgomery, RA
    Kuznicki, KA
    Leung-Chiu, AWM
    Bennett, KL
    DEVELOPMENTAL BIOLOGY, 2000, 222 (01) : 242 - 242
  • [22] Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus
    Peter B. Rosenthal
    Xiaodong Zhang
    Frank Formanowski
    Wolfgang Fitz
    Chi-Huey Wong
    Herbert Meier-Ewert
    John J. Skehel
    Don C. Wiley
    Nature, 1998, 396 : 92 - 96
  • [23] Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus
    Rosenthal, PB
    Zhang, XD
    Formanowski, F
    Fitz, W
    Wong, CH
    Meier-Ewert, H
    Skehel, JJ
    Wiley, DC
    NATURE, 1998, 396 (6706) : 92 - 96
  • [24] Reverse Genetics Approaches for the Development of Influenza Vaccines
    Nogales, Aitor
    Martinez-Sobrido, Luis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01)
  • [25] Generation of attenuated influenza virus by reverse genetics
    Castrucci, MR
    Mitnaul, LJ
    Wells, K
    Murti, KG
    Kawaoka, Y
    OPTIONS FOR THE CONTROL OF INFLUENZA III, 1996, 1123 : 795 - 802
  • [26] Progress of reverse genetics technique in influenza virus
    Liu Da-Fei
    Liu Chun-Guo
    Liu Ming
    Liu Da-Cheng
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (08) : 867 - 874
  • [27] Influenza reverse genetics: dissecting immunity and pathogenesis
    Ye, Siying
    Evans, Justin G.
    Stambas, John
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2014, 16
  • [28] Influenza Reverse Genetics-Historical Perspective
    Neumann, Gabriele
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2021, 11 (04):
  • [29] Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material
    Luykx, DMAM
    Casteleijn, MG
    Jiskoot, W
    Westdijk, J
    Jongen, PM
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 (01) : 65 - 75
  • [30] STUDIES WITH ANTIBODY TO PURIFIED HAEMAGGLUTININ OF AN INFLUENZA-AO VIRUS
    SCHILD, GC
    JOURNAL OF GENERAL VIROLOGY, 1970, 9 (DEC): : 191 - &